Cayae1 polynucleotides
US5869290A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 21, 1996 |
| Grant date | Feb 9, 1999 |
| Priority date | — |
| Expiry date | Nov 21, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/824
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides caYAE1 polypeptides and DNA (RNA) encoding such caYAE1 and a procedure for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing such caYAE1 for the treatment of infection, particularly fungal infections. Antagonists against such caYAE1 and their use as a therapeutic to treat infections, particularly fungal infections are also provided. Further provided are diagnostic assays for detecting diseases related to the presence of caYAE1 nucleic acid sequences and the polypeptides in a host. Also provided are diagnostic assays for detecting polynucleotides encoding caYAE1 and for detecting the polypeptide in a host.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.